Skip to Main Content

Paper Details

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.
Nat Commun
39
2020
FOXA1, FOXA1 plexus, FOXA1 regulatory plexus, Prostate cancer, androgen, androgen receptor, cis-regulatory elements, malignancy, men, primary and metastatic prostate tumors, primary prostate tumors, prostate cancer, prostate cancer cell, prostate tumors
Binding Sites, Cell Line, Tumor, Cell Proliferation, Gene Expression Regulation, Neoplastic, Hepatocyte Nuclear Factor 3-alpha, Humans, Male, Mutation, Prostatic Neoplasms, Regulatory Sequences, Nucleic Acid, Transcription Factors
Author NameAffiliation
Stanley ZhouPrincess Margaret Cancer Centre, University Health Network
Stanley ZhouUniversity of Toronto
James R HawleyPrincess Margaret Cancer Centre, University Health Network
James R HawleyUniversity of Toronto
Fraser SoaresPrincess Margaret Cancer Centre, University Health Network
Giacomo GrilloPrincess Margaret Cancer Centre, University Health Network
Mona TengPrincess Margaret Cancer Centre, University Health Network
Mona TengUniversity of Toronto
Seyed Ali Madani TonekaboniPrincess Margaret Cancer Centre, University Health Network
Seyed Ali Madani TonekaboniUniversity of Toronto
Junjie T HuaPrincess Margaret Cancer Centre, University Health Network
Junjie T HuaUniversity of Toronto
Ken J KronPrincess Margaret Cancer Centre, University Health Network
Parisa MazrooeiPrincess Margaret Cancer Centre, University Health Network
Parisa MazrooeiUniversity of Toronto
Musaddeque AhmedPrincess Margaret Cancer Centre, University Health Network
Christopher ArlidgePrincess Margaret Cancer Centre, University Health Network
Hwa Young YunPrincess Margaret Cancer Centre, University Health Network
Julie LivingstoneOntario Institute for Cancer Research
Vincent HuangOntario Institute for Cancer Research
Takafumi N YamaguchiOntario Institute for Cancer Research
Shadrielle Melijah G EspirituOntario Institute for Cancer Research
Yanyun ZhuOncode Institute, the Netherlands Cancer Institute
Tesa M SeversonOncode Institute, the Netherlands Cancer Institute
Alex MurisonPrincess Margaret Cancer Centre, University Health Network
Sarina CameronPrincess Margaret Cancer Centre, University Health Network
Wilbert ZwartOncode Institute, the Netherlands Cancer Institute
Wilbert ZwartLaboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology
Theodorus H van der KwastUniversity of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughOntario Institute for Cancer Research
Trevor J PughUniversity of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughOntario Institute for Cancer Research
Michael FraserOntario Institute for Cancer Research
Paul C BoutrosUniversity of Toronto
Paul C BoutrosOntario Institute for Cancer Research
Paul C BoutrosUniversity of Toronto
Paul C BoutrosUniversity of California los angeles
Paul C BoutrosUniversity of California los angeles
Paul C BoutrosInstitute for Precision Health, University of California los angeles
Paul C BoutrosJonsson Comprehensive Cancer Center, University of California los angeles
Robert G BristowPrincess Margaret Cancer Centre, University Health Network
Robert G BristowUniversity of Toronto
Robert G BristowUniversity of Toronto
Robert G BristowCRUK Manchester Institute and Manchester Cancer Research Centre
Robert G BristowUniversity of Manchester
Robert G BristowThe Christie NHS Foundation Trust
Housheng Hansen HePrincess Margaret Cancer Centre, University Health Network
  • 1 - 50

Datasets

Release 1.2